Regulations.gov document
Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal…
Notice · FDA-2013-D-0811 · posted Nov 29, 2022
Key facts
| Document ID | FDA-2013-D-0811-0153 |
|---|---|
| Title | Enforcement Policy Regarding Investigational New Drug Requirements for Use of Fecal Microbiota for Transplantation To Treat Clostridioides difficile Infection Not Responsive to Standard Therapies; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2013-D-0811 |
| Posted | Nov 29, 2022 |
| Federal Register citation | 87 FR 73313 |
| FR document number | 2022-26000 |
| Comment period opens | Nov 29, 2022 |
| Effective date | Nov 29, 2022 |
At a glance
- 1–9 Pages
- 100–999 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: